- Investing Ideas
- German Pharmaceuticals & Biotech High Growth Potential Companies
German Pharmaceuticals & Biotech High Growth Potential Companies
Results
8
Companies with a Future performance score of at least 3, ordered by Future performance score.
8 companies
Darwin
Market Cap: €95.4m
Operates in the healthcare industry.
7V0
€7.95
7D
32.5%
1Y
n/a
Cantourage Group
Market Cap: €75.6m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€6.06
7D
-7.6%
1Y
-7.3%
SynBiotic
Market Cap: €9.4m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€1.38
7D
-18.5%
1Y
-60.5%
Formycon
Market Cap: €353.1m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.98
7D
-0.6%
1Y
-25.0%
Gerresheimer
Market Cap: €844.8m
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€24.46
7D
-1.0%
1Y
-43.1%
Bayer
Market Cap: €35.4b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€36.01
7D
1.5%
1Y
32.6%
Evotec
Market Cap: €835.4m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€4.70
7D
-1.1%
1Y
-32.9%
MPH Health Care
Market Cap: €116.9m
An investment company, engages in the healthcare business in Germany.
93M1
€27.80
7D
-0.4%
1Y
42.6%